Skip to content
Search

Latest Stories

‘Outrage’: NPA slams government over 2025/26 GP contract as pharmacies await current year’s terms

NPA slams 2025-26 GP contract
Photo: iStock

The National Pharmacy Association (NPA) has come down heavily on the government, terming the GP contract offer a year ahead of pharmacies ‘an outrage’.

The government has on Thursday unveiled the first details of the next GP contract for 2025-26, including an extra £889 million ‘on top of the existing budget’ for general practice.


“It is an outrage that GP's have been offered their contract for the next financial year before pharmacies have even received an offer for the current year – nine months late,” Paul Rees, NPA chief executive, commented.

“There is huge strength of feeling among our members about their current financial position and this does nothing to reduce the chance of pharmacies being forced to take collective action to protect their services for patients.”

Last month, 99 per cent of NPA members voted in favour of limiting services to patients for the first time in its history if current levels of government underfunding is not reversed.

In the historic ballot, 97.8 per cent voted to serve notice on opening hours above the minimum required by their contract, with pharmacies being shut on weekends or weekday evenings whilst 93.3 per cent voted to withdraw making free home deliveries of medicines.

“The seemingly endless delays to this year’s contract negotiations only reinforces the belief that there is a lack of respect for pharmacies within government and leaves hardworking pharmacies abandoned in the dark, causing them stress and uncertainty about their future,” Rees said.

“Uncertainty about funding is preventing pharmacies from investing in better services and reform – instead making them take on debts or question whether they can continue at all.”

Rees asked the government to “get around the table” as soon as is possible to end the “crippling uncertainty and offer reassurance and security” to pharmacies.

Responding to the announcement, Community Pharmacy England chief executive Janet Morrison said: “It is extraordinary that the government has announced what looks to be a generous investment in general practice for 2025/26 before settling the contract for community pharmacies – many of whom are on the brink of collapse – for this financial year.

“For desperate pharmacy owners working hard to support their patients despite intolerable financial and operational pressures, today’s announcement will feel like more evidence of the inequity at the heart of primary care, and it is a further kick while they are down.”

She said the ongoing delays to Community Pharmacy Contractual Framework (CPCF) negotiations are “infuriating,” adding that: “It is clearly in everyone’s interests to have a strong general practice service, but without a stable network of community pharmacies to support them, any efforts to ease pressure on GPs will be wasted.”

While welcoming the assurances this week from ministers that the CPCF negotiations will commence early in the New Year, she said this will not be enough.

“Government and the NHS cannot be in any doubt that community pharmacies are chronically and dangerously underfunded and need urgent help. “Every further delay is likely too late for some pharmacy business and the communities and patients they serve. Community pharmacies simply cannot wait any longer for the good news they so desperately need,” she said.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less